China Cord Blood Corporation (CO)

Last Closing Price: 2.99 (2022-09-26)

Company Description

Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $196.12M
Net Income (Most Recent Fiscal Year) $79.04M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) 4.67
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.47
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 4.19
Pre-Tax Margin (Trailing 12 Months) 50.50%
Net Margin (Trailing 12 Months) 40.29%
Return on Equity (Trailing 12 Months) 10.63%
Return on Assets (Trailing 12 Months) 6.02%
Current Ratio (Most Recent Fiscal Quarter) 10.73
Quick Ratio (Most Recent Fiscal Quarter) 10.66
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 4.51
Book Value per Share (Most Recent Fiscal Quarter) $6.34
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $0.64
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding --
Free Float --
Market Capitalization $363.15M
Average Volume (Last 20 Days) 0.00
Beta (Past 60 Months) -0.03
Percentage Held By Insiders (Latest Annual Proxy Report) --
Percentage Held By Institutions (Latest 13F Reports) --
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%